International Journal of Microbiology
Volume 2017 (2017), Article ID 5402748, 6 pages
https://doi.org/10.1155/2017/5402748

Research Article

Persistence of Toxic Activity of Fermentation Extracts from Bacillus thuringiensis var. israelensis after More Than Three Decades of Storage

Luis Jesús Galán-Wong,¹ Rossana Gamiño-Hernández,¹ David Fernández-Chapa,¹ Graciela García-Díaz,¹ Myriam A. De La Garza-Ramos,² Claudio Guajardo-Barbosa,¹ and Hugo Alberto Luna-Olvera¹

¹Instituto de Biotecnología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, Ciudad Universitaria, 66450 San Nicolás de los Garza, NL, Mexico
²Centro de Investigación/Facultad de Odontología, Universidad Autónoma de Nuevo León, Calle Dr. Eduardo Aguirre Pequeño y Silao s/n, Colonia Mitras Centro, 64460 Monterrey, NL, Mexico

Correspondence should be addressed to Luis Jesús Galán-Wong; ljgw55@gmail.com

Received 4 August 2017; Revised 11 October 2017; Accepted 31 October 2017; Published 20 November 2017

Academic Editor: Giuseppe Comi

Copyright © 2017 Luis Jesús Galán-Wong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

This study was carried out to determine the persistence of toxicity of fermentation extracts of Bacillus thuringiensis var. israelensis after more than three decades of storage. For this purpose, a population of Aedes aegypti was established. The mortality rate of 20 spore-crystal extracts purified using the acetone-lactose coprecipitation method was measured and evaluated by bioassays according to a modified WHO protocol. The extracts with the highest mortality rate were determined in triplicate by their LD₅₀ and LD₉₈. All extracts showed toxicity at the highest tested dose (1000 ppm) and some, such as strains 3260 and 3501, still killed larvae at doses as low as 0.01 ppm. These data are surprising because no study on the activity of B. thuringiensis toxic proteins after such a long storage time has been reported.

1. Introduction

Mosquitoes today represent one of the most serious threats to public health because of their hematophagous nature and vector capacity. Some genera, such as Aedes, Anopheles, and Culex, transmit pathogens and parasites (viruses, protozoa, or nematodes) that cause devastating diseases such as dengue, Zika, chikungunya, encephalitis, yellow fever, malaria, and elephantiasis, which together are responsible for high morbidity and mortality in billions of people spread over almost half of the planet [1–6].

The need for more environmentally friendly insecticides and the increased resistance to chemicals have provided an excellent opportunity to eradicate mosquitoes with biological products based on Bacillus thuringiensis var. israelensis (Bti). These bacteria conserve parasporal crystals and spores of the H-14 serotype, which when ingested by mosquito larvae are solubilized in the alkaline environment of the midgut. This leads to the activation of insecticidal proteins of the crystal which bind to receptors in the cell wall and form intestinal pores that result in larvae death. This insecticidal effect is produced by four toxins known as Cry4A, Cry4B, Cry11Aa, and Cyt1A. Their main attributes are high toxicity and specificity towards family Culicidae [7–9].

Since its discovery and description by Goldberg and Margalit [10], Bti has shown remarkable effectiveness in killing mosquitoes, in contrast to its innocuousness to humans and other mammals, aquatic vertebrates, invertebrates, and plants. Because of these characteristics, commercial preparations of these bacteria have been chosen for mosquito control programs [11–14]. Dulmage et al. [15] were among the most important pioneers in the development of technologies for the implementation of Bti as a biological pest control agent. They established diverse methodologies for mass production, product formulation, and power standardization. From these processes, several hundred fermentation extracts of cultures belonging to this microorganism, characterized by their insecticidal activity against Dipteran, were donated by the United States Department of Agriculture in 1989 to our research group. Since then, these extracts have been kept in the Universidad Autónoma de Nuevo Leon (UANL) International Collection of Entomopathogenic Bacilli. Particularly important within this collection are 20 fermentation extracts, which we decided to utilize in this research to prove their ability to kill mosquitoes under laboratory conditions through their residual activity.

2. Materials and Methods

2.1. Bti Strains

Bti fermentation extracts from the collection of Dulmage et al. [15] recovered by lactose-acetone coprecipitation during the period from 1978 to 1983 were chosen. During this period, the extracts were stored in the dark in a dry space exclusively for this purpose at °C in sterile and hermetic bottles. Twenty-four samples of the strain HD-500 and twenty-five of HD-567 were observed under the microscope with a simple Coomassie blue stain to ascertain the absence of contamination (Figure 1). They were then activated in Petri dishes and incubated in BD Bioxon nutrient agar for 72 hours to demonstrate their viability and, subsequently, samples that displayed viability were selected.

Figure 1: Diagram of experimental procedure.

2.2. Mosquitoes

The larvae of the third and fourth instars of A. aegypti used in these experiments were obtained from the insectary of the Institute of Biotechnology of the School of Biology of the UANL. This mosquito colony is permanently maintained under pathogen-free conditions at 28 to 30°C with 60 to 80% relative humidity and light/dark cycles of 12 h. Under these conditions, the cycle from egg to adult is completed in three to four weeks. The larvae were fed daily with finely ground presterilized dog food (Pedigree brand). The pupae were removed daily to control the age of the mosquito and placed in a container that was introduced into a cage for 48 h for the emergence of adult mosquitoes. Cages of different sizes were used according to the magnitude of the mosquito population, which was fed daily with a 10% glucose solution soaked in cotton swabs and every 3 days with a blood source for 10 min. Oviposition of the females was stimulated with an ovitrap consisting of a water container covered with brown paper. Collected eggs were transferred to trays to perpetuate the cycle in such a way that larvae used in all the experiments were available.

2.3. Standard Preparation

As a positive control (100% mortality), a primary standard was prepared from VectoBac® 3000 UTI/mg (Valent BioSciences Corp. Libertyville, IL) at a concentration of 0.05 ppm. This was placed in Petri dishes with nutritive agar. Broth was taken and transferred to nutrient broth and incubated at 30°C at 150 rpm for 12 hours until an optical density greater than 1 (2 × 10⁸ CFU/ml), measured with a spectrophotometer at a wavelength of 540 nm, was reached. An aliquot of 1 ml in triplicate was added to 500 ml Erlenmeyer flasks with 100 ml of Bti medium (unpublished experimental medium) to verify the potency of the extracts. Distilled water was used as a negative control (Figure 1).

2.4. Bioassays

The World Health Organization guidelines for laboratory bioassays of bacterial larvicides were followed [16]. Suspensions of each fermentation extract were prepared at 2000 ppm in Erlenmeyer flasks. Dilutions were then made to obtain final concentrations of 1000, 100, 10, 1, 0.1, and 0.01, respectively. Transparent plastic cups with 250 ml capacity were used with 150 ml per vessel and 25 larvae of the second or third stage were added (Figure 1). To calculate LD₅₀ of the fermentation extracts, three suspensions of 2%, 50%, and 98% were prepared. The positive control was performed in duplicate with the primary standard. Results were tabulated according to dose, considering the number of live and dead mosquitoes with 4 replications per treatment performed in triplicate at 24 hours. To calculate LD₅₀, a linear regression was applied using the R statistical package, 2015 [17]. Bioassays were carried out at least three times and the validity of the results was evaluated with the primary extract obtained from VectoBac.

3. Results

Of the 49 Bti fermentation extracts from the collection, only 20 still contained spores as protein crystals; therefore, only these were used in the bioassays. Dead larvae were counted every 6 hours during a 24-hour period (Table 1). In this case, dying larvae were included to calculate the mortality rate. Most of these Bti extracts showed some toxic activity towards mosquito larvae in high concentrations, but their activity decreased as the dilution increased (Table 1). Thus, at 1000 ppm, up to 18 extracts managed to kill larvae to some degree; in fact, 10 extracts were 100% effective. This same trend was observed at 100 ppm, where only the extract from strain 3299 was unable to kill all test insects, but at 10 ppm only 5 of the extracts maintained this potency. An interesting fact was observed for the extract of strain 3260. Even at concentrations of 1 and 0.1, it maintained its toxic activity unaltered to kill all of the larvae. However, at a higher dilution (0.01 ppm), the extract was unable to maintain its residual activity (Figure 2). It is worth noting that the toxic activity of both the commercial product, VectoBac, and the laboratory preparation produced from it (VA) was maintained even at the lowest concentrations under our experimental conditions and together with strains 3260 and 3501 also showed a consistent ability to kill mosquito larvae at the lowest concentrations. Thus, LD₅₀ and LD₉₈ were and ; and ; and and  ppm for VectoBac, 3260, and 3501, respectively (Figure 3).

Table 1: Dead larvae counted every 6 hours after exposure to the extracts.

Treatment
Dead larvae  

Concentration (ppm)/time (h)

0.01
0.1
1
10
100
1000

1
6
12
18
24
1
6
12
18
24
1
6
12
18
24
1
6
12
18
24
1
6
12
18
24
1
6
12
18
24

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

2858
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

3826
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

3859
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

3350
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2

3549
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
4

3553
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
4
5

3356
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
4
6

3824
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
6
8

3552
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
6
10

3825
0
0
0
0
0
0
0
0
1
3
0
0
2
4
5
0
0
2
3
6
0
1
2
5
9
0
3
5
8
12

3299
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
8
14
19
23

3779
0
0
0
0
0
0
0
0
1
1
0
0
1
4
5
0
1
3
7
11
4
11
17
21
24
8
20
25
25
25

3353
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
0
2
6
9
10
0
6
15
22
25
11
23
25
25
25

3691
0
0
0
0
0
0
0
0
3
5
0
0
1
4
13
0
4
12
19
24
2
12
22
25
25
23
25
25
25
25

3505
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
4
5
8
20
25
25
25
25
25
25
25
25

3857
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
2
14
24
25
25
25
25
25
25
25
25

3756
0
0
0
0
0
0
0
0
1
1
0
0
2
4
5
4
9
18
21
24
13
25
25
25
25
25
25
25
25
25

3696
0
0
0
0
0
0
0
0
1
4
0
0
3
5
8
0
5
14
19
23
9
25
25
25
25
25
25
25
25
25

3501
0
0
0
0
0
0
0
0
2
6
0
2
6
10
13
14
24
25
25
25
25
25
25
25
25
25
25
25
25
25

3260
0
0
1
3
3
2
8
10
10
13
16
25
25
25
25
23
25
25
25
25
25
25
25
25
25
25
25
25
25
25

VA
16
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25

VC
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25
25

indicates average of four replications in three separate experiments; indicates distilled water. VA: activated VectoBac; VC: commercial VectoBac.

Figure 2: Toxicity of Bacillus thuringiensis var. israelensis fermentation extracts at different concentrations against Aedes aegypti (VC, commercial VectoBac; VA, activated VectoBac).

Figure 3: LD₅₀ and LD₉₈ of fermentation extracts 3501 and 3260 from Bacillus thuringiensis var. israelensis.

4. Discussion

Our findings demonstrate the persistence of toxic activity of fermentation extracts of Bti against A. aegypti after three decades of storage. All extracts studied showed toxicity at the highest tested doses (1000 ppm) and some of the extracts, from strains 3260 and 3501, still killed larvae at doses as low as 0.01 ppm. Such data are surprising, since no study to date has reported the activity of B. thuringiensis toxic proteins after such a long storage time. On the other hand, the few reports on the persistence of toxicity in the field or under controlled conditions indicate that these proteins quickly lose their insecticidal properties due to different causes. Among the environmental factors that negatively affect the persistence of toxicity are temperature [18], solar radiation [19], pH [20], and organic matter [21]. However, other authors have shown that some conditions favor the possibility of increasing their persistence. For example, Saxena et al. [22] showed that Cry proteins from Bt maize root exudates maintained their larvicidal activity for more than 180 days in soil, while Tapp and Stotzky [23] reported this same toxic capacity more than 234 days after their incorporation into soil. This is probably a result of their binding to the clay particles of the porous matrix. In our case, the Bti protein crystals of the tested extracts were covered for more than three decades with the lactose matrix used during obtention of the fermentation extract. This suggests the important role that this disaccharide could have in maintaining the activity of the toxic proteins of the different Bti strains particularly stable after this period of time. In other varieties of this bacterium from the same collection of fermentation extracts (unpublished data), whose protective mechanism is still uncertain, the same effect does not appear. Although the activity of the extracts of Bti was found to be very low compared to treatment with VectoBac, it is notable that most maintained residual activity at the highest concentrations tested, and two of these extracts stood out at the minimum concentrations at which they could kill mosquito larvae. This is an encouraging sign regarding the possibility of improving the use of special strains and improved formulations to control insect vectors of diseases.

5. Conclusions

Fermentation extracts from Bacillus thuringiensis var. israelensis maintained their residual toxic activity against Aedes aegypti larvae after storage at °C in the aforementioned conditions for more than three decades. Extracts 3260 and 3501 showed LD₅₀ of 0.12 and 1.16 ppm, respectively. This work demonstrates that Bti protein crystals can prolong their toxicity in shelf life or field conditions under specific conditions.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

E. Calvez, L. Guillaumot, L. Millet et al., “Genetic Diversity and Phylogeny of Aedes aegypti, the Main Arbovirus Vector in the Pacific,” PLOS Neglected Tropical Diseases, vol. 10, no. 1, Article ID e0004374, 2016.

R. Eritja, R. Escosa, J. Lucientes et al., “Worldwide invasion of vector mosquitoes: Present European distribution and challenges for Spain,” Biological Invasions, vol. 7, no. 1, pp. 87–97, 2005.

F. Cui, M. Raymond, and C.-L. Qiao, “Insecticide resistance in vector mosquitoes in China,” Pest Management Science, vol. 62, no. 11, pp. 1013–1022, 2006.

P. Gautret and F. Simon, “Dengue, chikungunya and Zika and mass gatherings: What happened in Brazil, 2014,” Travel Medicine and Infectious Disease, vol. 14, no. 1, pp. 7-8, 2016.

H. Liu, Y. Lu, Q. Liu et al., “Comparison of pyrethroid resistance in adults and larvae of Culex pipiens pallens (Diptera: Culicidae) from four field populations in China,” Journal of Economic Entomology, vol. 106, no. 1, pp. 360–365, 2013.

C. B. Marcondes and M. D. F. F. D. M. Ximenes, “Zika virus in Brazil and the danger of infestation by aedes (Stegomyia) mosquitoes,” Journal of the Brazilian Society of Tropical Medicine, vol. 49, no. 1, pp. 4–10, 2016.

E. Ben-Dov, “Bacillus thuringiensis subsp. Israelensis and Its dipteran-specific toxins,” Toxins, vol. 6, no. 4, pp. 1222–1243, 2014.

G. P. Georghiou and M. C. Wirth, “Influence of exposure to single versus multiple toxins of Bacillus thuringiensis subsp. israelensis on development of resistance in the mosquito Culex quinquefasciatus (Diptera: Culicidae),” Applied and Environmental Microbiology, vol. 63, no. 3, pp. 1095–1101, 1997.

M. C. Wirth, A. Delécluse, B. A. Federici, and W. E. Walton, “Variable cross-resistance to Cry11B from bacillus thuringiensis subsp. jegathesan in culex quinquefasciatus (diptera: culicidae) resistant to single or multiple toxins of bacillus thuringienisis subsp. israelensis,” Applied and Environmental Microbiology, vol. 64, no. 11, pp. 4174–4179, 1998.

L. J. Goldberg and J. Margalit, “A bacterial spore demonstrating rapid larvicidal activity against Anopheles sergentii, Uranotaenia unguiculata, Culex univitattus, Aedes aegypti and Culex pipiens,” Mosquito News, vol. 37, pp. 355–358, 1977.

T. M. Watson and B. H. Kay, “Vector Competence of Aedes notoscriptus (Diptera: Culicidae) for Ross River Virus in Queensland, Australia,” Journal of Medical Entomology, vol. 35, no. 2, pp. 104–106, 1998.

A. M. Boyd and B. H. Kay, “Vector competence of Aedes aegypti, culex sitiens, culex annulirostris, and culex quinquefasciatus (diptera: culicidae) for barmah forest virus,” Journal of Medical Entomology, vol. 37, no. 5, pp. 660–663, 2000.

T. L. Russell, M. D. Brown, D. M. Purdie, P. A. Ryan, and B. H. Kay, “Efficacy of VectoBac (Bacillus thuringiensis variety israelensis) formulations for mosquito control in Australia,” Journal of Economic Entomology, vol. 96, no. 6, pp. 1786–1791, 2003.

L. A. Lacey, “Bacillus thuringiensis serovariety Israelensis and bacillus sphaericus for mosquito control,” Journal of the American Mosquito Control Association, vol. 23, no. 2, pp. 133–163, 2007.

H. T. Dulmage, J. A. Correa, and A. J. Martinez, “Coprecipitation with lactose as a means of recovering the spore-crystal complex of Bacillus thuringiensis,” Journal of Invertebrate Pathology, vol. 15, no. 1, pp. 15–20, 1970.

World Health Organization, “Guidelines for laboratory and field testing of mosquito larvicides,” pp. 1-41, Geneva, 2005.

R Core Team, R: A language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria, 2014.

S. P. Wraight, D. Molloy, H. Jamnback, and P. McCoy, “Effects of temperature and instar on the efficacy of bacillus thuringiensis var. israelensis and Bacillus sphaericus strain 1593 against aedes stimulans larvae,” Journal of Invertebrate Pathology, vol. 38, no. 1, pp. 78–87, 1981.

N. Becker, M. Zgomba, M. Ludwig, D. Petric, and F. Rettich, “Factors influencing the activity of Bacillus thuringiensis var. israelensis treatments,” Journal of the American Mosquito Control Association, vol. 8, no. 3, pp. 285–289, 1992.

C. Ignoffo, C. Garcia, M. Kroha, T. Fukuda, and T. Couch, “Laboratory tests to evaluate the potential efficacy of Bacillus thuringiensis var. israelensis for use against mosquitoes,” Mosquito News, vol. 41, pp. 85–93, 1981.

F. W. Van Essen and S. C. Hembree, “Simulated field studies with four formulations of Bacillus thuringiensis var. israelensis against mosquitoes: residual activity and effect of soil constituents,” Mosquito News, vol. 42, no. 1, pp. 66–72, 1982.

D. Saxena, S. Flores, and G. Stotzky, “Insecticidal toxin in root exudates from Bt corn,” Nature, vol. 402, no. 6761, p. 480, 1999.

H. Tapp and G. Stotzky, “Persistence of the insecticidal toxin from Bacillus thuringiensis subsp. Kurstaki in soil,” Soil Biology and Biochemistry, vol. 30, no. 4, pp. 471–476, 1998.